IL72731A - Stable antibacterial lyophilizate preparations of 7-difluoromethyl thioacetamino-7-methoxy-3-(1-(2-hydroxy lower alkyl)-1h-tetrazol-5-yl)thio-methyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid alkali metal salts and methods for the production thereof - Google Patents

Stable antibacterial lyophilizate preparations of 7-difluoromethyl thioacetamino-7-methoxy-3-(1-(2-hydroxy lower alkyl)-1h-tetrazol-5-yl)thio-methyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid alkali metal salts and methods for the production thereof

Info

Publication number
IL72731A
IL72731A IL72731A IL7273184A IL72731A IL 72731 A IL72731 A IL 72731A IL 72731 A IL72731 A IL 72731A IL 7273184 A IL7273184 A IL 7273184A IL 72731 A IL72731 A IL 72731A
Authority
IL
Israel
Prior art keywords
thioacetamino
dethia
cephem
lyophilizate
tetrazol
Prior art date
Application number
IL72731A
Other languages
English (en)
Other versions
IL72731A0 (en
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of IL72731A0 publication Critical patent/IL72731A0/xx
Publication of IL72731A publication Critical patent/IL72731A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
IL72731A 1983-08-22 1984-08-21 Stable antibacterial lyophilizate preparations of 7-difluoromethyl thioacetamino-7-methoxy-3-(1-(2-hydroxy lower alkyl)-1h-tetrazol-5-yl)thio-methyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid alkali metal salts and methods for the production thereof IL72731A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58153938A JPS6045514A (ja) 1983-08-22 1983-08-22 安定な抗菌性凍結乾燥製剤

Publications (2)

Publication Number Publication Date
IL72731A0 IL72731A0 (en) 1984-11-30
IL72731A true IL72731A (en) 1988-04-29

Family

ID=15573358

Family Applications (1)

Application Number Title Priority Date Filing Date
IL72731A IL72731A (en) 1983-08-22 1984-08-21 Stable antibacterial lyophilizate preparations of 7-difluoromethyl thioacetamino-7-methoxy-3-(1-(2-hydroxy lower alkyl)-1h-tetrazol-5-yl)thio-methyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid alkali metal salts and methods for the production thereof

Country Status (20)

Country Link
US (1) US4616083A (de)
EP (1) EP0134568B1 (de)
JP (1) JPS6045514A (de)
KR (1) KR910004575B1 (de)
AR (1) AR242390A1 (de)
AT (1) ATE38774T1 (de)
CA (1) CA1231896A (de)
DE (2) DE3475268D1 (de)
DK (1) DK163032C (de)
ES (1) ES535654A0 (de)
FI (1) FI83476C (de)
GB (1) GB2145333B (de)
GR (1) GR80147B (de)
IE (1) IE57587B1 (de)
IL (1) IL72731A (de)
NO (1) NO165223C (de)
NZ (1) NZ209111A (de)
PT (1) PT79093B (de)
SU (1) SU1433390A3 (de)
ZA (1) ZA846104B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61130223A (ja) * 1984-11-28 1986-06-18 Shionogi & Co Ltd 抗菌性凍結乾燥製剤
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
KR0154343B1 (ko) * 1990-11-06 1998-11-16 아만 히데아키 동결 건조 제제 및 이의 제조방법
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
AU2003241675A1 (en) * 2002-06-21 2004-01-06 Shionogi And Co., Ltd. Medicinal cephem compound composition for injection
KR101314500B1 (ko) 2012-12-28 2013-10-07 제일약품주식회사 안정성이 개선된 옥사세펨 제제 및 그 제조방법
KR102226197B1 (ko) 2013-03-15 2021-03-11 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US9320740B2 (en) 2013-03-15 2016-04-26 Merck Sharp & Dohme Corp. Ceftolozane-tazobactam pharmaceutical compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
WO2016035846A1 (ja) * 2014-09-04 2016-03-10 塩野義製薬株式会社 カテコール基を有するセファロスポリン類を含有する製剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA919593A (en) * 1969-03-31 1973-01-23 Nippon Kayaku Kabushiki Kaisha Process for manufacturing a preparation containing finely divided chloramphenicol palmitate
US3993753A (en) * 1974-08-26 1976-11-23 American Home Products Corporation Anhydrous ampicillin stabilization and resultant compositions
US4180571A (en) * 1976-03-25 1979-12-25 Shionogi & Co., Ltd. Arylmalonamido-1-oxadethiacephalosporins
JPS5711909A (en) * 1980-06-23 1982-01-21 Shionogi & Co Ltd Stable freeze-dried preparation of beta-lactam
JPS5762284A (en) * 1980-10-01 1982-04-15 Sumitomo Chem Co Ltd Stabilizing method
JPS59139385A (ja) * 1982-12-23 1984-08-10 Shionogi & Co Ltd フルオロメチルチオオキサセフアロスポリン

Also Published As

Publication number Publication date
GB8420296D0 (en) 1984-09-12
KR850001687A (ko) 1985-04-01
IE842072L (en) 1985-02-22
NZ209111A (en) 1987-02-20
FI843261A0 (fi) 1984-08-17
JPS6045514A (ja) 1985-03-12
DK163032C (da) 1992-06-15
US4616083A (en) 1986-10-07
NO843313L (no) 1985-02-25
ES8505815A1 (es) 1985-06-16
EP0134568B1 (de) 1988-11-23
GB2145333B (en) 1987-01-07
FI843261A (fi) 1985-02-23
ATE38774T1 (de) 1988-12-15
AR242390A1 (es) 1993-03-31
DK399684D0 (da) 1984-08-21
ZA846104B (en) 1985-03-27
NO165223C (no) 1991-01-30
FI83476C (fi) 1991-07-25
NO165223B (no) 1990-10-08
ES535654A0 (es) 1985-06-16
DE3475268D1 (en) 1988-12-29
DK163032B (da) 1992-01-13
FI83476B (fi) 1991-04-15
IE57587B1 (en) 1993-01-13
SU1433390A3 (ru) 1988-10-23
PT79093B (en) 1986-08-14
EP0134568A1 (de) 1985-03-20
IL72731A0 (en) 1984-11-30
JPH0370688B2 (de) 1991-11-08
DE134568T1 (de) 1985-08-29
PT79093A (en) 1984-09-01
DK399684A (da) 1985-02-23
GB2145333A (en) 1985-03-27
GR80147B (en) 1984-12-18
CA1231896A (en) 1988-01-26
KR910004575B1 (ko) 1991-07-06

Similar Documents

Publication Publication Date Title
JPS574914A (en) Manufacture of aqueous solution of water- insoluble or water-hard-soluble compound
DE3470415D1 (en) Acid salts of valproic acid
IL72731A (en) Stable antibacterial lyophilizate preparations of 7-difluoromethyl thioacetamino-7-methoxy-3-(1-(2-hydroxy lower alkyl)-1h-tetrazol-5-yl)thio-methyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid alkali metal salts and methods for the production thereof
ZA844540B (en) Oxamic acid derivatives
PL246433A1 (en) Agent for genetic transformation of dicotyledons
JPS57150645A (en) Manufacture of sodium salt aqueous solution of alpha-aminocarboxyic acid
HK61289A (en) Use of salicylic acid derivatives as anti-smut agents
IL63136A (en) Stabilized 7beta-(alpha-carboxy-alpha-(p-hydroxyphenyl acetamido) 7alpha-methoxy-3-heterocyclylthiomethyl-1-dethia-1-oxa-3-cephem-4-carboxylic acid alkali metal salt preparations and process for preparing them
JPS57212139A (en) Manufacture of 6-hydroxy-2-naphthoic acid
JPS5681569A (en) Salt of dihaloo22quinoxalinecarboxylic acid
GB8423929D0 (en) Stabilization of dilute aqueous solutions
AR240554A1 (es) Procedimiento para preparar derivados del acido azulen-3-sulfonico y sus sales
ZA849905B (en) Nutrient solution containing alpha-ketoisocaproic acid or one of its salts
DE3263557D1 (en) Process for the preparation of quinolinic acid
PT75636B (en) Method for the preparation of 3-phenyl-1-indamines isomers thereof and acid addition salts
JPS5683440A (en) Manufacture of phenoxypropionic acid and its alkali salt
DE3465188D1 (en) Acid salts of valproic acid
DE3167735D1 (en) Process for the preparation of alkali metal salts of imidodisulphonic acid
GB2103212B (en) 4-substituted derivatives of 2-oxo-1-azetidinesulfonic acid salts
GB8327834D0 (en) 2-phenoxypropionic acid derivatives of pentites
DE3367772D1 (en) Process for the preparation of 3-carboxy-1-methylpyrrol-2-acetic-acid and alkali metal salts thereof
JPS568362A (en) Manufacture of 55aroyll11lower alkylpyrrolee 22acetic acid salt
DE3474912D1 (en) Use of 2-pentanoylaminoacetic acid and salts thereof
DE3463381D1 (en) Process for the preparation of alkyl esters of cis-chrysanthemic acid, and compounds obtained
DE3479209D1 (en) Salts of antimalarial phenanthrenemethanol compounds

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired